Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)

HKD 14.0

(-0.99%)

Market Cap (In HKD)

65.78 Billion

Revenue (In HKD)

41.39 Billion

Net Income (In HKD)

2.38 Billion

Avg. Volume

2.91 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.32-19.5
PE
-
EPS
-
Beta Value
0.724
ISIN
CNE100001M79
CUSIP
Y7687D109
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Deyong Wen
Employee Count
-
Website
https://www.fosunpharma.com
Ipo Date
2012-10-30
Details
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.